Steering Committee

The implementation of the strategy is based on a Steering Group for the implementation of personalised medicine. The Steering Group ensures a clear joint public responsibility for and collaboration on the development, implementation and operation of the national infrastructure for personalised medicine with special focus on whole genome sequencing during the strategy period 2021-2022


Dorte Bech Vizard, representative from the Danish Ministry of Health

Deputy Chairman

Kurt Espersen, koncerndirektør i Region Syddanmark

Deputy Chairman

Bettina Lungren, CEO at Danish National Genome Center